Objective: To determine the natural history and treatment options for patients with intracochlear schwannomas. Methods: Seven patients with intracochlear schwannomas which where confined to the otic capsule were identified in a retrospective chart review at a tertiary referral center. Their histories were examined and the following characteristics were noted:1) presenting and associated symptoms, 2) initial MRI scan findings, 3) surgical interventions (if any), and 4) follow up MRI results. Results: All seven patients in our series presented with hearing loss. Tinnitus and vertigo were equally prevalent at 43%. Meanwhile, no patient presented with aural fullness or facial weakness. Of the seven patients, six had observational follow up MRIs with only one patient having any changes in MRI. Two out of the seven patients required surgical intervention for intractable vertigo which resulted in resolution of symptoms.
Introduction
Intracochlear schwannomas are rare clinical entities that present with hearing loss vertigo, tinnitus, and rarely aural fullness. Historically, due to lack of specific investigational tools, cases of intracochlear and in general, intralabyrinthine schwannomas were often diagnosed as Meniere's disease. 1 Prior to the advent of magnetic resonance imaging (MRI), intracochlear schwannomas were only definitively found intra-operatively or during post-mortem autopsies.
MRI allowed schwannomas to be found at earlier stages. T1 images with gadolinium will show enhancement within the cochlea. Whereas, T2 images will show cut off or amputation of the cochlear signal when a schwannoma is present. 2 Labyrinthitis, hemorrhage, and ossification can also cause loss of signal on T2, therefore, T1 imaging may be used to exclude certain competing diagnoses. High-resolution fast spin echo (FSE) T2-weighted MRI and traditional T1 gadolinium enhanced MRI are both equally sensitive to detect vestibular schwannomas. 3 Due to its location, intracochlear schwannomas typically present with sensorineural hearing loss. Hearing loss is usually progressive but approximately 15-32% of cases can present with sudden hearing loss. 2, 4 Occasionally, a mixed type hearing loss can occur, presumably due to blockage of inner ear fluid by the tumor. This may dampen the stapes footplate. 4 Furthermore, the tumor may cause secondary endolymphatic hydrops which may result in disequilibrium and vertigo. 5, 6 
Methods
Seven patients with intracochlear schwannomas with no extension into the vestibule or internal auditory canal were identified in a retrospective chart review at a tertiary referral center. Their histories were examined and the following characteristics were noted:1) presenting and associated symptoms, 2) initial MRI scan findings, 3) surgical interventions (if any), and 4) follow up MRI results.
Results
All the patients in this series presented with hearing loss (see table 1 ). In all cases except one in which the hearing loss was "severe to profound", hearing loss was profound. Tinnitus and vertigo were both equally prevalent at 43%. Meanwhile, no patients in our series presented with any aural fullness or facial weakness.
Out of the seven patients in our series, six of the patients had follow up MRI scans. Only one patient definitively had any change in the tumor size (case 2). The patient in case 5 had a previous scan in 1999 that we did not have access to, therefore it is indeterminate was to whether the intracochlear schwannoma was simply not noticed on previous scans or whether it is a new finding. 
Case Presentations

Discussion
Hearing loss was the most prevalent presenting symptom, followed by tinnitus and vertigo equally in our series. This mirrors a previous report of 68 cases where hearing loss was the presenting symptom in 93% of cases, and tinnitus (50%) and vertigo (51%). 7 Indications for surgical intervention in a patient with a intracochlear schwannoma include: 1) intolerable vertigo, 2) extension of the tumor into the CPA or middle ear, 3) evidence of tumor growth, or 4) concern for pathologic diagnosis. Based on these indications, it was found that tumors that involve the IAC required surgery more often than tumors confined to the labyrinth (46% vs. 7%) 4 The surgical approach selected for removal of intracochlear schwannomas depends entirely on the location of the tumor and whether extension into the internal auditory canal is present. Tumors confined to the cochlea can be removed using a post auricular transcanal transotic approach. Care must be taken not to injure petrous carotid artery. The first genu of the petrous carotid artery can be as close as 1 mm from the inferior and ascending junction of the basal turn of the cochlea. Limiting the dissection inferior to the cochleariform process will prevent a facial nerve injury when opening the middle turn of the cochlea. The traditional transmastoid transotic approach will be necessary in tumors that extend into the internal auditory canal. Entering the modiolus will result in egress of CSF from the posterior fossa into the middle ear. The middle ear and Eustachian tube will then need to be obliterated to prevent a CSF leak.
Hearing preservation has not been reported in patients undergoing resection of intracochlear schwannomas. Anacusis often occurs as a result of the natural history of the tumor or after surgical removal. A BAHA, while not allowing for sound localization, can improve the head shadow effect and some measures of hearing in noise in patients with single sided deafness. 7 Non-operative management with annual MRI scans is an option when the patient still has residual hearing or if the patient is asymptomatic. In a recent study, it was found that in a series of 20 patients for which observation was the management, only 15% of the patients had any growth identified on subsequent MRI scans. 4 Even then, the tumors that grew were all transmodiolar (involving both the cochlea and the IAC), rather than pure intracochlear tumors. Indeed, in our study, only one of six patients on follow up had any noticeable change in tumor size. It is interesting to note that tumor growth is not necessarily associated with changes in symptoms. For example in case 3, the patient developed vertigo despite an unchanged MRI. Similarly in case 2, the tumor size increased but the patient had no symptomatic change. The reported average growth of vestibular schwannomas is 1.8-2.4mm/year. 8, 9 Published reports of tumor growth with observation range from 53% to 82%, although these represents schwannomas in general, rather than those restricted to the cochlea. 8,9 
